2024-05 – 2023 Annual Report
Serodus ASA - Publishes 2023 Annual Report Download it here
2024-04 – Q1 2024 Reporting
As a consequence of Board decision in December 2023, screening of new patients is stopped. The last patient last visit will be August 2024. Report expected to be finalized in…
2024-01 – Q4 2023 Reporting
After an initial increasing in screening and randomization activities of patients to the SER150 CL-009 study in New Zealand this has slowed down. Recruitment of patients in Australia remains very…
2023-10 – Q3 2023 Reporting
Screening of patients in New Zealand improved after visiting the clinical centres involved in SER150 CL-009 study. The broaden of inclusion criteria for recruitment of patients to theSER150 CL-009 study…
2023-09 – Q2 2023 Reporting
Screening of patients in New Zealand has now improved after visiting the clinical centres involved in SER150 CL-009 study. To facilitate enrolment, the entrance criteria will be revised for the…
2023-06 – Investor Meeting in Copenhagen
Address: Stokholmsgade 412100 Copenhagen E June 21, 2023, at 15:00Please reserve the date